4-1BB is upregulated on activated CD4+ and CD8+ T-cells, as well as NK cells. So the ADR wouldn't just deplete (a subset of) Tregs, it could also affect activated antitumour T-cells and/or NK cells. Hopefully, they will look at this and present data in the near future.
Market Data 
Markets 
AI
